Artigo Revisado por pares

Pyothorax-Associated Lymphoma

2002; Lippincott Williams & Wilkins; Volume: 26; Issue: 6 Linguagem: Inglês

10.1097/00000478-200206000-00005

ISSN

1532-0979

Autores

Bruno Petitjean, Fabrice Jardin, Bertrand Joly, Nadine Martin‐Garcia, Hervé Tilly, Jean‐Michel Picquenot, Josette Brière, Claire Danel, S. Mehaut, Issam Abd‐Alsamad, Christiane Copie‐Bergman, Marie‐Hélène Delfau‐Larue, Philippe Gaulard,

Tópico(s)

Immune Cell Function and Interaction

Resumo

We report 12 European cases of pyothorax-associated lymphomas occurring 30-67 years following artificial pneumothorax for pleuropulmonar tuberculosis. Eleven patients presented with a localized pleural tumor mass, whereas one patient also had liver involvement. Histologic examination showed a diffuse proliferation of large lymphoid cells with frequent plasmacytoid differentiation (n = 8), expressing CD20 (n = 10), CD79a (n = 11), and/or CD138 (n = 5) B-cell antigens. Aberrant expression of T-cell markers (CD2, CD3, CD4) was noted in five cases. The B-cell origin of lymphoma cells was confirmed by the demonstration of immunoglobulin light chain restriction or clonal B cell population in six cases. In 11 of 12 cases in situ hybridization disclosed Epstein-Barr virus genome in most tumor cells and immunohistochemistry a type III LMP-1+/ EBNA-2+ latency profile. HHV-8/ORF73 antigen was not detected in all tested cases (n = 11). All investigated cases (10 of 10) disclosed a uniform CD10-/BCL-6-/MUM1+/CD138+/- phenotype, consistent with a derivation from late germinal center (GC)/post-GC B cells. Clinical outcome was poor with a median survival time of 5 months. Only one patient was in complete remission after 34 months. This study further confirms that pyothorax-associated lymphoma represents a distinct clinicopathologic entity among diffuse large B-cell lymphoma, which is characterized by a peculiar clinical presentation, frequent plasmacytoid features, and a strong association with EBV. Moreover, we show that this lymphoma entity likely originates from B cells at a late stage of differentiation and occasionally shares an aberrant dual B/T phenotype.

Referência(s)